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Effects of Atorvastatin on Development of Peritoneal Sclerosis in Rats on 
Peritoneal Dialysis 
Background: Peritoneal sclerosis is one of the important complications of long 
term peritoneal dialysis. In this study, we aimed to test the effects of atorvastatin on peritoneal 
functions and peritoneal histology in non-uremic rats on peritoneal dialysis. 
Methods: Twenty-two non-uremic Wistar albino rats were allocated into three 
groups: Sham(10 mL saline intraperitoneally for four weeks), Peritoneal dialysis (PD,10 mL 
hypertonic dialysis solution intraperitoneally for four weeks) and treatment (Tx, 10 mL 
hypertonic dialysis solution intraperitoneally + atorvastatin in drinking water for four weeks) 
groups. At the end of four weeks, one-hour peritoneal equilibration test performed, serum 
lipids, certain cytokines, mediators antioxidant enzyme activities and markers (IL-1β, IL-6, Il-
8, TGF-β, TNF-α, NO, GSH, GPx, GR, CAT, MDA) in serum and/or dialysate were 
evaluated. Peritoneal thickness was measured and peritoneal inflammation, fibrosis and 
vascularisation were evaluated in histological sections. 
Results: In histological examinations, inflammation, fibrosis and vascularisation 
were more frequently observed in PD group when compared to that of the sham group and it 
seemed to decrease when atorvastatin used in conjunction with peritoneal dialysis. 
Additionally peritoneum was thicker in PD group when compared to that of the sham group 
and Tx groups. When serum samples were examined, there was no significant difference 
between the parameters. On the other hand, dialysate GR activity and TGF-β were 
significantly lower in Tx group than that of the PD group whereas dialysate IL-6 level was 
higher in to group than that of PD group. 
Conclusions: Our study suggests that atorvastatin use diminish structural changes 
in peritoneum. Decreased expression of TGF-β in dialysate may be one of the possible 
underlying mechanisms. 
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